<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04143971</url>
  </required_header>
  <id_info>
    <org_study_id>896</org_study_id>
    <nct_id>NCT04143971</nct_id>
  </id_info>
  <brief_title>Intermittent Fasting in Hypertriglyceridemic Overweight or Obese Subjects</brief_title>
  <official_title>Effects of Intermittent Fasting Compared to Continuous Calorie Restriction on Weight Loss &amp; Plasma Lipids in Hypertriglyceridemic Overweight or Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shahid Beheshti University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      some studies have shown similar effects of intermittent fasting and continuous caloric
      restriction on body weight and plasma lipid profile, but there is still a wide controversy.
      Therefore,due to limited human studies and the lack of a study on hypertriglyceridemic
      patients, the present study aimed to determine the effects of using low-calorie diets in
      comparison with continuous caloric restriction on weight loss and plasma lipid profile in
      obese or overweight hypertriglyceridemic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      a randomized clinical trial will be conducted in National Nutrition and Food Technology
      Research Institute, Tehran, Iran. after the review of inclusion and exclusion criteria, a
      written consent form will be completed. the participants will be 90 hypertriglyceridemic
      patients aged between 18-60. half of the participants will be under intermittent low-calorie
      diet which they will have 3 alternate days in the week eating only 30% of their total energy
      requirement and on the other days of the week they receive a total calorie of 100% of their
      energy requirement , therefore there will be a total of -210% TEE reduction in their received
      energy in the week. the other group will be under continuous calorie restriction meaning on
      all the days of the week they will be eating 70% of their total energy requirement resulting
      in a total of -210% TEE reduction in their received energy in the week. both groups will
      receive 3 consultation sessions with a nutritionist, also to prevent any deficiency,
      multi-vitamin-mineral supplements will be given to both groups participants.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2, 2019</start_date>
  <completion_date type="Actual">May 20, 2020</completion_date>
  <primary_completion_date type="Actual">March 12, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>at 8 weeks</time_frame>
    <description>Mean weight change of participants (kg) after 8 weeks of diets</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma Triglycerides</measure>
    <time_frame>at 8 weeks</time_frame>
    <description>Mean change in plasma triglycerides of participants after 8 weeks of diets</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Hypertriglyceridemia</condition>
  <condition>Overweight or Obesity</condition>
  <arm_group>
    <arm_group_label>Continiuous Low calorie diets</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Low calorie diet with daily calorie restriction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intermittent Fasting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intermittent fasting every other day, in which daily calorie intake will be up to 30% of required calorie.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intermittent fasting diet</intervention_name>
    <description>intermittent fasting diet</description>
    <arm_group_label>Intermittent Fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>low calorie diet</intervention_name>
    <description>continuous low calorie diet</description>
    <arm_group_label>Continiuous Low calorie diets</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hypertriglyceridemic : TG&gt;150 mg/dL

          -  BMI&gt;24.9

          -  age 18-60

          -  non-smoker

          -  haven't been under any diet at least 3 months before participating in the study

          -  not starting any new exercise program or changing the previous exercise while in the
             study

        Exclusion Criteria:

          -  chronic kidney disease stage 3-5

          -  consuming Insulin or Insulin-inducing drugs.

          -  consuming triglycerides lowering drugs or Omega 3

          -  a history of cholecystitis

          -  Heart arrhythmia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical Nutrition Research Unit, National Nutrition and Food Technology Research Institute</name>
      <address>
        <city>Tehran</city>
        <zip>19395-4741</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>October 27, 2019</study_first_submitted>
  <study_first_submitted_qc>October 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>May 24, 2020</last_update_submitted>
  <last_update_submitted_qc>May 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University</investigator_affiliation>
    <investigator_full_name>Javad Nasrollahzadeh</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>intermittent fasting</keyword>
  <keyword>hypertriglyceridemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertriglyceridemia</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

